Quantcast

PENNSYLVANIA RECORD

Thursday, November 21, 2024

Case activity for Jamie Leidenfrost vs Teva Pharmaceuticals USA Inc. on Feb. 25

Filings
General court 05

shutterstock.com

The U.S. District Court for the Eastern District of Pennsylvania reported the following activities in the suit brought by Jamie Leidenfrost against Coopersurgical Inc., Duramed Pharmaceuticals Inc. a Division of Barr Pharmaceuticals, INC. D B a Teva Women's Health, INC., Teva Branded Pharmaceutical Products R&D Inc., Teva Pharmaceuticals USA Inc., Teva Women's Health Inc., Individually, and, Teva Women's Health LLC, Individually and and The Cooper Companies Inc. on Feb. 25.

'Notice Of Removal By Coopersurgical, Inc., Teva Women's Health Llc F/k/a Teva Women's Health, Inc., The Cooper Companies, Inc., Teva Pharmaceuticals Usa, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. D/b/a Teva Women's Health, Inc., Teva Branded Pharmaceutical Products R&d, Inc., Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc. (filing Fee $ 402 Receipt Number 0313-14942632), Filed By Coopersurgical, Inc., Teva Women's Health Llc F/k/a Teva Women's Health, Inc., The Cooper Companies, Inc., Teva Pharmaceuticals Usa, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. D/b/A Teva Women's Health, Inc., Teva Branded Pharmaceutical Products R&d, Inc., Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 By The Cooper Companies, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including The Cooper Companies, Inc. By Coopersurgical, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Branded Pharmaceutical Products R&d, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Pharmaceuticals Usa, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health Llc F/k/A Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health Llc F/k/A Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'

Case number 2:21-cv-00885 was filed in the U.S. District Court for the Eastern District of Pennsylvania on Feb. 25.

More News